Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hyperparathyroidism Secondary

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hyperparathyroidism Secondary:

Pubmed Logo
Physiology and pathophysiology of the calcium-sensing receptor in the kidney.
The extracellular calcium-sensing receptor (CaSR) plays a major role in...
20th November, 2009
Cardiff Universtiy. Am J Physiol Renal Physiol. 2009 Nov 18.
DOI Direct Link
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol.
BACKGROUND: Secondary hyperparathyroidism is a common feature in patients...
13th November, 2009
Medical Department, Roskilde Hospital, Koegevej 7-13, DK-4000 Roskilde, BMC Nephrol. 2009 Sep 24;10:28.
DOI Direct Link
Management of co-morbid diseases in a patient with established renal failure.
This follows on from an article relating to chronic kidney disease (CKD)...
30th October, 2009
J Ren Care. 2009 Sep;35(3):151-8.
DOI Direct Link
Aggressive control of secondary hyperparathyroidism can result in immediate efficient blood pressure control in dialysis patients.
This follows on from an article relating to chronic kidney disease (CKD)...
29th October, 2009
Dialysis Unit, Veliki Clinic, Katerini, Greece. Nephrology (Carlton). 2009 Aug;14(5):535-6.
DOI Direct Link
The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
BACKGROUND: The calcium sending receptor (CaSR) allows parathyroid and...
29th October, 2009
Departments of Molecular Genetics, Haydarpasa Numune Research and Training Clin Nephrol. 2009 Aug;72(2):114-21.

View more research publications.

Press Releases About Hyperparathyroidism Secondary:

BioPortfolio Logo
AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 24th November, 2009 AETERNA ZENTARIS INC.
Primary efficacy endpoint has been met for patients with advanced-stage or recurrent endometrial cancer QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS;
Reportlinker Adds European Markets for Dental Dental Growth Factors 2009 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. European Markets for Dental Dental Growth Factors 2009 http://www
Reportlinker Adds U.S. Market for PACS and EMR 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. U.S. Market for PACS and EMR http://www.reportlinker.com/p0164740/US
Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. India Dental Devices Investment Opportunities, Analysis and Forecasts to
Reportlinker Adds Asia Pacific Markets for Dental Implants and Final Abutments 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Asia Pacific Markets for Dental Implants and Final Abutments http://www

BioNews Results for Hyperparathyroidism Secondary:

RSS Logo
BioPortfolio Logo
Secondary Hyperparathyroidism: Pathophysiology and Treatment
Medscape:  Nov 10 2009 11:53PM Matching: hyperparathyroidism secondary
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency
MDLinx:  Oct 28 2009 12:54PM Matching: hyperparathyroidism secondary

Hyperparathyroidism Secondary Patents:

USPTO Logo
US Patent No.Title
7582658 Bicyclic compound
6310226 Vitamin D analogues
6197982 Vitamin D analogues
5994332 Vitamin D analogues
5932565 Vitamin D analogues

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hyperparathyroidism Secondary scientists - we have details of around 351 individuals working on Hyperparathyroidism Secondary .


This page has been viewed 306 times
Recent Search Terms used to find this page: hyperparathyroidism pathophysiology | working with hyperparathyroidism | Clin Calcium. 2009 Apr 19 4 493-9. | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis FREE downloD | hyperparathyroidism in animals | Hyperparathyroidism secondary to zoledronic acid infusion case report | 1alpha 24 S OH 2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase CYP27B1 -deficient mice an animal model of vitamin D deficiency with secondary hyperparathyroidism | Prevalence of secondary hyperparathyroidism and chronic kidney disease | cinacalcet wikepedia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hyperparathyroidism Secondary across BioPortfolio, or for Hyperparathyroidism Secondary Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.